Quick summary

Betony (Stachys officinalis) is a medicinal herb historically used in traditional European herbalism. Current scientific research evidence is limited and pending, with no high-quality randomized controlled trials or systematic reviews specifically evaluating its clinical efficacy and safety for human health conditions.

What is it

Betony, scientifically known as Stachys officinalis, is a perennial herb native to Europe. It has a long history of use in traditional herbal medicine, particularly in Central Europe, and is recognized by its distinctive serrated leaves and purple flowers.

Traditional uses

Historically, Betony has been used in Central European herbal medicine for a wide range of ailments, including respiratory, gynecological, cardiovascular, and gastrointestinal conditions. These uses are documented in herbalist recipes dating from the 17th to the 19th century.

Active compounds

The specific active compounds in Betony have not been thoroughly characterized in modern clinical research. Traditionally, it is believed to contain various phytochemicals typical of the Lamiaceae family, including flavonoids and phenolic acids, but detailed scientific analysis is lacking.

Potential benefits with evidence levels

  • Potential adjunctive use in polycystic ovary syndrome (PCOS) treatment

    Evidence level: Insufficient clinical evidence

    A 2025 systematic review suggested Betony as part of herbal medications potentially useful when combined with other PCOS treatments. However, no clinical trials or direct outcomes on Betony alone are available.
  • Traditional historical uses for various ailments

    Evidence level: Ethnopharmacological/traditional use

    Used historically for respiratory, gynecological, cardiovascular, and gastrointestinal issues based on herbalist practices from the 17th to 19th centuries.

Side effects

No adverse effects specifically related to Betony have been reported in available clinical or preclinical data. However, contemporary safety data in humans are lacking.

Drug interactions

There are no documented drug interactions involving Betony (Stachys officinalis) identified in the current literature.

Who should avoid it

No specific contraindications have been established for Betony. However, due to lack of safety data, pregnant or breastfeeding individuals should exercise caution and consult healthcare providers before use.

Evidence limitations

  • No randomized controlled trials or meta-analyses specifically evaluating Betony’s efficacy or safety in humans.
  • Lack of clinical toxicity, pharmacokinetic, or safety profile studies.
  • Most available information is historical, ethnopharmacological, or derived from reviews including Betony as part of polyherbal formulations without isolated clinical data.
  • No direct mechanistic or clinical outcome data to support use for specific health conditions.
  • Absence of research on pharmacological interactions or contraindications.
  • The generalizability and applicability of historical uses to modern clinical practice are uncertain.

References

  • Wani R, Shaikh M. Healing with Herbs: A Systematic Review of Natural Treatments for Polycystic Ovary Syndrome. 2025.
    https://europepmc.org/articles/PMC12225173 (PMID: 40080781)
  • Spałek K, Spielvogel I, Proćków M, Proćków J. Historical ethnopharmacology of the herbalists from Krummhübel in the Sudety Mountains (seventeenth to nineteenth century), Silesia. 2019.
    https://europepmc.org/articles/PMC6533749 (PMID: 31122247)
  • Various Crossref and OpenAlex metadata entries on Stachys officinalis and related herbal medicine reviews, 2019-2026.
    Note: No direct clinical trial or systematic review evidence on Betony’s efficacy or safety identified.

Last reviewed

June 2024

Informational disclaimer: This page is for educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified